Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio (2016 - 2026)

Ironwood Pharmaceuticals' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.75 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 21.31% to 0.75 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.75, a 21.31% decrease, with the full-year FY2025 number at 0.79, down 7.37% from a year prior.
  • Asset Utilization Ratio hit 0.75 in Q4 2025 for Ironwood Pharmaceuticals, down from 0.92 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for IRWD hit a ceiling of 0.96 in Q3 2024 and a floor of 0.37 in Q1 2023.
  • Historically, Asset Utilization Ratio has averaged 0.67 across 5 years, with a median of 0.72 in 2025.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 53.56% in 2021 and later surged 145.79% in 2024.
  • Tracing IRWD's Asset Utilization Ratio over 5 years: stood at 0.38 in 2021, then grew by 2.27% to 0.38 in 2022, then surged by 131.97% to 0.89 in 2023, then grew by 6.68% to 0.95 in 2024, then decreased by 21.31% to 0.75 in 2025.
  • Business Quant data shows Asset Utilization Ratio for IRWD at 0.75 in Q4 2025, 0.92 in Q3 2025, and 0.92 in Q2 2025.